6FA-27230-25427 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-21
Dose 1 — Pfizer-BioNTech
2022-08-12
Dose 2 — Pfizer-BioNTech
2022-10-12
Dose 3 — Pfizer-BioNTech
2022-10-13
Registered in v-safe
2022-10-13
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-10-15
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-10-16
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-10-17
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-11-02
Survey response — day 21, dose 3, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Good

Free text: Runny nose and cough

MedDRA releases: 2024-11 · check-in free text available
2022-11-09
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-11-18
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-11-23
Health check-in — day 42, dose 3, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-21	Pfizer-BioNTech	No
2	2022-08-12	Pfizer-BioNTech	No
3	2022-10-12	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 21, dose 3, under 3

2022-11-02

Symptoms: Runny nose and cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release